Opinion | The Attack on an Alzheimer’s Drug

Photo: /Associated Press Public-health and media critics failed to stop federal approval of Aduhelm, Biogen’s new drug for Alzheimer’s. So now they’re mounting an assault on the drug’s cost to stop Medicare from paying for it. Their sudden and rare … Read more

Opinion | Two Cheers for Biden’s Vaccine Donation

President Joe Biden speaks about his administration’s global COVID-19 vaccination efforts ahead of the G-7 summit in St. Ives, England, June 10. Photo: Patrick Semansky/Associated Press President Biden announced at the G-7 summit on Thursday that the U.S. will donate … Read more

Opinion | America’s Energy Gift to Dictators

The U.S. is barreling toward one of the greatest self-inflicted wounds in its history. This came into sharper focus last week when President Biden suspended oil leases in Alaska’s Arctic National Wildlife Refuge (ANWR), even as Russia and the Organization … Read more

Opinion | An Alzheimer’s Breakthrough, At Last

A Biogen researcher works on the development of the medication aducanumab in Cambridge, Mass. Photo: David A. White/Associated Press The Food and Drug Administration gave hope to millions of Americans suffering from Alzheimer’s disease on Monday by approving Biogen’s aducanumab, … Read more